Tech Company Financing Transactions
Iantrek Funding Round
Iantrek closed a $23 million Series B financing round on 8/30/2022. Backers included Sectoral Asset Management and Visionary Venture Fund.
Transaction Overview
Company Name
Announced On
8/30/2022
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Series B
Investors
Sectoral Asset Management (Lead Investor) (Marc Marcotle)
Visionary Venture Fund (Lead Investor) (Farrell Tyson)
Proceeds Purpose
The capital will be used to initiate clinical introduction and post-marketing studies of Iantrek's Micro-Interventional Glaucoma Surgical (MIGS) devices in the United States.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
151 E Post Rd 110-111
White Plains, NY 10601
USA
White Plains, NY 10601
USA
Phone
Website
Email Address
Overview
Developer of a minimally invasive technology designed to offer ophthalmic medical devices. The company offers advanced micro-interventional surgical technologies, enabling clients to go through eye surgery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean Ianchulev
Chief Financial Officer
Michael Haydin
Chief Operating Officer
David Robson
Browse more venture capital transactions:
Prev: 8/30/2022: Pezesha venture capital transaction
Next: 8/30/2022: Mavenoid venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs